These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 26314237)
1. Controversies in the Management of Isolated Congenital Atrioventricular Block. DeNoble AE; Kuller JA; Rhee EJ Obstet Gynecol Surv; 2015 Aug; 70(8):518-23. PubMed ID: 26314237 [TBL] [Abstract][Full Text] [Related]
2. Predictive markers and prenatal management of isolated fetal complete atrioventricular block: A retrospective review at a single institution. Murakami K; Yamamoto Y; Fukunaga H; Matsushita M; Hirai C; Makino S; Shimizu T; Itakura A; Takeda S J Obstet Gynaecol Res; 2018 Feb; 44(2):228-233. PubMed ID: 29160028 [TBL] [Abstract][Full Text] [Related]
3. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block. Mevorach D; Elchalal U; Rein AJ Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727 [TBL] [Abstract][Full Text] [Related]
4. The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block. Fesslova V; Vignati G; Brucato A; De Sanctis M; Butera G; Pisoni MP; Chiappa E; Acaia B; Meroni PL Cardiol Young; 2009 Jun; 19(3):282-90. PubMed ID: 19383179 [TBL] [Abstract][Full Text] [Related]
5. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Jaeggi ET; Fouron JC; Silverman ED; Ryan G; Smallhorn J; Hornberger LK Circulation; 2004 Sep; 110(12):1542-8. PubMed ID: 15353508 [TBL] [Abstract][Full Text] [Related]
6. Immune-Mediated Fetal Complete Atrioventricular Block: Can Dexamethasone Therapy Revert the Process? Perles Z; Ishay Y; Nir A; Gavri S; Golender J; Ta-Shma A; Abu-Zahira I; Natsheh J; Elchalal U; Mevorach D; Rein AJ Isr Med Assoc J; 2020 Nov; 11(22):711-716. PubMed ID: 33249793 [TBL] [Abstract][Full Text] [Related]
7. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study. Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471 [TBL] [Abstract][Full Text] [Related]
8. Isolated congenital atrioventricular block diagnosed in utero: natural history and outcome. Breur JM; Kapusta L; Stoutenbeek P; Visser GH; van den Berg P; Meijboom EJ J Matern Fetal Neonatal Med; 2008 Jul; 21(7):469-76. PubMed ID: 18570127 [TBL] [Abstract][Full Text] [Related]
9. Causes of fetal third-degree atrioventricular block and use of hydroxychloroquine in pregnant women with Ro/La antibodies. Mollerach FB; Scolnik M; Catoggio LJ; Rosa J; Soriano ER Clin Rheumatol; 2019 Aug; 38(8):2211-2217. PubMed ID: 30997589 [TBL] [Abstract][Full Text] [Related]
10. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review. Hutter D; Silverman ED; Jaeggi ET Scand J Immunol; 2010 Sep; 72(3):235-41. PubMed ID: 20696021 [TBL] [Abstract][Full Text] [Related]
11. Late development of complete atrioventricular block may be immune mediated and congenital in origin. Bergman G; Skog A; Tingström J; Ottosson V; Hoxha A; Ambrosi A; ; Salomonsson S; Wahren-Herlenius M Acta Paediatr; 2014 Mar; 103(3):275-81. PubMed ID: 24164657 [TBL] [Abstract][Full Text] [Related]
12. A combination therapy protocol of plasmapheresis, intravenous immunoglobulins and betamethasone to treat anti-Ro/La-related congenital atrioventricular block. A case series and review of the literature. Ruffatti A; Marson P; Svaluto-Moreolo G; Marozio L; Tibaldi M; Favaro M; Calligaro A; Grava C; Hoxha A; Pengo V; Punzi L Autoimmun Rev; 2013 May; 12(7):768-73. PubMed ID: 23340276 [TBL] [Abstract][Full Text] [Related]